These results suggest the potential prognostic role of CD44 expression as a marker of more aggressive laryngeal carcinoma independent of its grade and stage; high CD44 expression was observed in low-grade (G2) and advanced-stage carcinomas with lymph node metastasis at the time of diagnosis. This evidence concerns the gene CD44 and metastatic malignant neoplasm in the lymph nodes.